$2.23 Billion is the total value of Slate Path Capital LP's 30 reported holdings in Q2 2019. The portfolio turnover from Q1 2019 to Q2 2019 was 183.3% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| SPY | New | SPDR S&P 500 ETF TRcall | $586,000,000 | – | 2,000,000 | +100.0% | 26.28% | – |
| CHTR | Buy | CHARTER COMMUNICATIONS INC Ncl a | $202,727,000 | +27.0% | 513,000 | +11.5% | 9.09% | -29.7% |
| GOLD | Buy | BARRICK GOLD CORPORATION | $195,785,000 | +24.0% | 12,415,000 | +7.8% | 8.78% | -31.3% |
| MDCO | Buy | MEDICINES CO | $129,286,000 | +113.2% | 3,545,000 | +63.4% | 5.80% | +18.0% |
| Z | Buy | ZILLOW GROUP INCcl c cap stk | $123,629,000 | +255.9% | 2,665,000 | +166.5% | 5.54% | +97.0% |
| KEX | Buy | KIRBY CORP | $107,835,000 | +74.0% | 1,365,000 | +65.5% | 4.84% | -3.6% |
| MOS | New | MOSAIC CO NEW | $73,964,000 | – | 2,955,000 | +100.0% | 3.32% | – |
| ALNY | Buy | ALNYLAM PHARMACEUTICALS INC | $44,624,000 | -0.5% | 615,000 | +28.1% | 2.00% | -44.9% |
| LYFT | New | LYFT INC | $40,412,000 | – | 615,000 | +100.0% | 1.81% | – |
| UBER | New | UBER TECHNOLOGIES INC | $37,568,000 | – | 810,000 | +100.0% | 1.68% | – |
| QQQ | New | INVESCO QQQ TRcall | $10,551,000 | – | 56,500 | +100.0% | 0.47% | – |
| CYCN | New | CYCLERION THERAPEUTICS INC | $8,176,000 | – | 714,018 | +100.0% | 0.37% | – |
| CF | New | CF INDS HLDGS INC | $4,718,000 | – | 101,000 | +100.0% | 0.21% | – |
| EEM | New | ISHARES TRcall | $4,034,000 | – | 94,000 | +100.0% | 0.18% | – |
| CTVA | New | CORTEVA INC | $3,253,000 | – | 110,000 | +100.0% | 0.15% | – |
| X | New | UNITED STATES STL CORP NEW | $3,215,000 | – | 210,000 | +100.0% | 0.14% | – |
| SBGL | New | SIBANYE STILLWATERsponsored adr | $2,660,000 | – | 560,000 | +100.0% | 0.12% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2019-08-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| CHARTER COMMUNICATIONS INC N | 30 | Q3 2023 | 15.2% |
| ALNYLAM PHARMACEUTICALS INC | 30 | Q3 2020 | 8.9% |
| UNITED STATES STL CORP NEW | 24 | Q3 2023 | 11.4% |
| NEW YORK TIMES CO | 23 | Q3 2023 | 10.9% |
| VANECK VECTORS ETF TR | 21 | Q3 2023 | 19.5% |
| PAN AMERN SILVER CORP | 21 | Q3 2023 | 7.6% |
| CUE BIOPHARMA INC | 17 | Q3 2023 | 1.3% |
| BARRICK GOLD CORPORATION | 16 | Q4 2020 | 15.7% |
| MOSAIC CO NEW | 15 | Q4 2021 | 16.8% |
| MEDICINES CO | 15 | Q4 2019 | 12.2% |
View Slate Path Capital LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Cue Biopharma, Inc. | February 14, 2023 | 2,402,455 | 5.6% |
| Stitch Fix, Inc. | February 14, 2023 | ? | ? |
| Cyclerion Therapeutics, Inc. | January 13, 2023 | 7,157,601 | 16.5% |
| Zimmer Energy Transition Acquisition Corp. | February 14, 2022 | 2,000,000 | 5.8% |
| 5:01 Acquisition Corp. | February 11, 2022 | 500,000 | 5.8% |
| Hippo Holdings Inc. | February 11, 2022 | 350,000 | 0.1% |
| Warner Music Group Corp. | February 11, 2022 | 3,134,779 | 2.6% |
| Reinvent Technology Partners Z | February 16, 2021 | 1,750,000 | 7.6% |
View Slate Path Capital LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-01-22 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| SC 13G/A | 2023-02-14 |
| SC 13G | 2023-02-14 |
| 13F-HR | 2023-02-14 |
| SC 13G | 2023-01-13 |
| SC 13G | 2022-11-18 |
View Slate Path Capital LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.